July 29, 2014 5:37 PM ET

Healthcare Equipment and Supplies

Company Overview of IntraPace, Inc.

Executive Profile

Eric Bell

Director, IntraPace, Inc.
AgeTotal Calculated CompensationThis person is connected to 2 Board Members in 2 different organizations across 2 different industries.

See Board Relationships
----

Background

Eric Bell is an Investment Professional at Vulcan Capital. Mr. Bell focuses on life sciences venture investments at Vulcan Capital. Prior to Vulcan, Mr. Bell headed the business development out-licensing efforts for cancer vaccines and innate, immuno-modulators for Corixa Corporation. Prior to Corixa, he served as Manager of Tredegar Investments, Inc., where he was actively involved with several successful biotechnology and medical device investments. Mr. Bell worked ...

Corporate Headquarters

967 Shoreline Boulevard
Mountain View, California 94043

United States

Phone: --
Fax: --

Board Members Memberships

Observer
2006-Present
Director

Education

MS
The University of Pennsylvania
BS
Worcester Polytechnic Institute
MBA
University of Pennsylvania - The Wharton School

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact IntraPace, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.